Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
Sage Therapeutics (NASDAQ: SAGE) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, at 8:15 a.m. PT in San Francisco, CA.
Investors and interested parties can access a live webcast of the presentation through the Investor page on Sage's website at investor.sagerx.com. The presentation recording will be available for replay and archived for up to 30 days following the event.
Sage Therapeutics (NASDAQ: SAGE) ha annunciato la sua prossima presentazione al 43° Annuale J.P. Morgan Healthcare Conference. La presentazione è programmata per mercoledì 15 gennaio 2025, alle 8:15 a.m. PT a San Francisco, CA.
Gli investitori e le parti interessate possono accedere a un webcast dal vivo della presentazione attraverso la pagina per gli investitori del sito web di Sage all'indirizzo investor.sagerx.com. La registrazione della presentazione sarà disponibile per la visione e archiviata per un massimo di 30 giorni dopo l'evento.
Sage Therapeutics (NASDAQ: SAGE) ha anunciado su próxima presentación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. La presentación está programada para el miércoles 15 de enero de 2025, a las 8:15 a.m. PT en San Francisco, CA.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la página para inversores en el sitio web de Sage en investor.sagerx.com. La grabación de la presentación estará disponible para su reproducción y archivada por un máximo de 30 días después del evento.
세이지 테라퓨틱스 (NASDAQ: SAGE)가 제43회 연례 J.P. 모건 헬스케어 컨퍼런스 발표를 예고했습니다. 발표는 2025년 1월 15일 수요일, 오전 8시 15분 PT에 샌프란시스코, CA에서 진행될 예정입니다.
투자자 및 관심 있는 당사자는 Sage의 웹사이트 투자자 페이지인 investor.sagerx.com을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표 녹화는 이벤트 이후 30일 동안 다시 볼 수 있도록 보관됩니다.
Sage Therapeutics (NASDAQ: SAGE) a annoncé sa prochaine présentation lors de la 43e Conférence Annuelle J.P. Morgan Healthcare. La présentation est prévue pour mercredi 15 janvier 2025, à 8h15 PT à San Francisco, CA.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la page des investisseurs sur le site web de Sage à l'adresse investor.sagerx.com. L'enregistrement de la présentation sera disponible pour rediffusion et archivé pendant 30 jours après l'événement.
Sage Therapeutics (NASDAQ: SAGE) hat seine bevorstehende Präsentation auf der 43. jährlichen J.P. Morgan Healthcare Conference angekündigt. Die Präsentation ist für Mittwoch, den 15. Januar 2025, um 8:15 Uhr PT in San Francisco, CA, angesetzt.
Investoren und Interessierte können über die Investoren-Seite auf der Website von Sage unter investor.sagerx.com auf ein Live-Webcast der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird für eine Wiederholung zur Verfügung stehen und für bis zu 30 Tage nach der Veranstaltung archiviert.
- None.
- None.
A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250108981499/en/
Investor
Katie Plante
Katie.Plante@sagerx.com
Media
Francesca Dellelci
Francesca.Dellelci@sagerx.com
Source: Sage Therapeutics
FAQ
When is Sage Therapeutics (SAGE) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Sage Therapeutics' 2025 J.P. Morgan Healthcare Conference presentation?
How long will the replay of Sage Therapeutics' J.P. Morgan presentation be available?
What is the significance of Sage Therapeutics presenting at the 2025 J.P. Morgan Healthcare Conference?
